ace393
Vaccineexperimental
Clinical trial activity
1 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2008 (NCT00859716)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Campylobacter jejuniImmunity, active
Campylobacter jejuni immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ace393
- ace393
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00859716 | Phase 2 | Oct 1, 2008 | Aptiv Solutions, Johns Hopkins University, SGS Life Sciences, Shin Nippon Biomedical Laboratories, TD Vaccines A/S, University of Vermont |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Aptiv Solutions | For profit | 1 | 0 | 1 | 2008 |
| Johns Hopkins University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| SGS Life Sciences | For profit | 1 | 0 | 1 | 2008 |
| Shin Nippon Biomedical Laboratories | For profit | 1 | 0 | 1 | 2008 |
| TD Vaccines A/S | For profit | 1 | 1 | 1 | 2008 |
| University of Vermont | Academic/Hospital | 1 | 0 | 1 | 2008 |
6 organizations
Page 1 / 1